Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "Pharmacologic Substance[C1909]|Biological Agent[C307]|Antineoplastic Biological Agent" in comments (approximate match)

Showing 111 - 120 of 183 results

First page
Previous page
Next page
Next page

FUTUXIMAB

B37J680LX0

Subunit 1 (452) Similarity Search Subunit 2 (452) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (452) Similarity Search Subunit 2 (452) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT03717038: Phase 3 Interventional Withdrawn Metastatic Colorectal Cancer

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03717038

Class:

PROTEIN

VORSETUZUMAB

XC95WX725U

Subunit 1 (448) Similarity Search Subunit 2 (448) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Sequence Search

Subunit 1 (448) Similarity Search Subunit 2 (448) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Status:

Investigational

Source:

NCT04227847: Phase 1 Interventional Recruiting Myelodysplastic Syndrome

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04227847

Class:

PROTEIN

ASCRINVACUMAB

716FQ5REVO

Subunit 1 (443) Similarity Search Subunit 2 (443) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Sequence Search

Subunit 1 (443) Similarity Search Subunit 2 (443) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Status:

Investigational

Source:

NCT01486368: Phase 2 Interventional Completed Malignant Pleural Mesothelioma

(2012)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01486368

Class:

PROTEIN

LINTUZUMAB

V00Y10W60W

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Sequence Search

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Status:

Investigational

Source:

NCT00528333: Phase 2 Interventional Completed Acute Myeloid Leukemia

(2007)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00528333

Class:

PROTEIN

MODOTUXIMAB

1W7BD1M08N

Subunit 1 (448) Similarity Search Subunit 2 (448) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Sequence Search

Subunit 1 (448) Similarity Search Subunit 2 (448) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Status:

Investigational

Source:

NCT03549338: Phase 2 Interventional Terminated Metastatic Colorectal Cancer

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03549338

Class:

PROTEIN

ENOTICUMAB

B59DCD0F7D

Subunit 1 (452) Similarity Search Subunit 2 (452) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (452) Similarity Search Subunit 2 (452) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

INN:enoticumab [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/B59DCD0F7D

Class:

PROTEIN

PARSATUZUMAB

435M4HCP2M

Subunit 1 (453) Similarity Search Subunit 2 (453) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Sequence Search

Subunit 1 (453) Similarity Search Subunit 2 (453) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Status:

Investigational

Source:

NCT01399684: Phase 2 Interventional Completed Metastatic Colorectal Cancer

(2011)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01399684

Class:

PROTEIN

DEMCIZUMAB

SF168W7FW0

Subunit 1 (444) Similarity Search Subunit 2 (444) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Sequence Search

Subunit 1 (444) Similarity Search Subunit 2 (444) Similarity Search Subunit 3 (218) Similarity Search Subunit 4 (218) Similarity Search

Status:

Investigational

Source:

NCT02289898: Phase 2 Interventional Completed Pancreatic Cancer

(2015)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02289898

Class:

PROTEIN

OREGOVOMAB

HX101E7L6S

Sequence Search

Status:

Investigational

Source:

NCT04498117: Phase 3 Interventional Active, not recruiting Carcinoma, Ovarian Epithelial

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04498117

Class:

PROTEIN

GLEMBATUMUMAB VEDOTIN

1568H6A58U

Subunit 1 (445) Similarity Search Subunit 2 (445) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Sequence Search

Subunit 1 (445) Similarity Search Subunit 2 (445) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Status:

Investigational

Source:

NCT02487979: Phase 2 Interventional Completed Recurrent Osteosarcoma

(2016)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02487979

Class:

PROTEIN

Protein

Protein

Protein

Protein

Protein

Protein

Protein

Protein

Protein

Protein

GLEMBATUMUMAB VEDOTIN

Showing 111 - 120 of 183 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1